Saadat Majeed
Papers
1
Total Citations
15
H-Index
1
About
Dr. Saadat Majeed is a rising leader in the rapidly evolving field of cancer nanomedicine, whose work is helping to define the next generation of precision oncology. Her research focuses on the strategic evolution of therapeutic nanoparticles, from passive accumulation via the enhanced permeability and retention (EPR) effect to sophisticated, active targeting and personalized drug delivery systems. In her highly cited 2025 review, "Recent advances in cancer nanomedicine: From smart targeting to personalized therapeutics," Dr. Majeed provides a critical, forward-looking synthesis of the field’s trajectory since the landmark approval of Doxil®. This work, already garnering 15 citations, maps a coherent continuum of progress—from early liposomal formulations to today’s programmable, stimuli-responsive nanocarriers. By articulating how smart targeting and patient-specific design are converging to create truly individualized treatments, Dr. Majeed is not only documenting history but actively shaping the roadmap for future breakthroughs. Her contributions are essential reading for anyone seeking to understand the practical path from laboratory innovation to clinical impact in the war on cancer.
Research Focus
Key Achievements
Top Papers
- 1